People In Brief
This article was originally published in The Gray Sheet
Executive Summary
Interventional pulmonology CEO: Emphysema device developer Pulmonx announced the hiring of Michael A. Baker as president and CEO July 15. Baker resigned from his 11-year post as CEO of ArthroCare in February in the shadow of an accounting scandal and government investigations (1"The Gray Sheet" Feb. 23, 2009). He also previously served as an executive for Medtronic. The Pulmonx announcement comes two months after the start-up acquired failed endobronchial valve-maker Emphasys Medical and several weeks following 510(k) clearance of its Chartis collateral ventilation detection system, which can be used to identify candidates best suited for lung volume reduction procedures using the Emphasys EBV valve (2"The Gray Sheet" May 18, 2009). Former CEO Ronald Steckel left the firm in November 2008
You may also be interested in...
People In Brief
MDMA chair: Delcath Systems' CEO Eamonn Hobbs took over the Medical Device Manufacturers Association board of directors as chairman May 25 during the group's annual meeting in Washington, D.C. He replaces outgoing chair Joe Kiani, CEO of Masimo. Hobbs joined Delcath, which develops novel delivery systems for cancer drugs, last July. He co-founded interventional radiology and oncology firm AngioDynamics in 1988 and served as its president and CEO until early 2009 (1"The Gray Sheet" July 20, 2009)
People In Brief
MDMA chair: Delcath Systems' CEO Eamonn Hobbs took over the Medical Device Manufacturers Association board of directors as chairman May 25 during the group's annual meeting in Washington, D.C. He replaces outgoing chair Joe Kiani, CEO of Masimo. Hobbs joined Delcath, which develops novel delivery systems for cancer drugs, last July. He co-founded interventional radiology and oncology firm AngioDynamics in 1988 and served as its president and CEO until early 2009 (1"The Gray Sheet" July 20, 2009)
People In Brief
Bayer and Thermo CEOs: Thermo Fisher Scientific CEO Marijn E. Dekkers has resigned to take the CEO post of pharmaceutical giant and glucose monitor maker Bayer. Dekkers will not take the helm of Bayer until Oct. 1, 2010, when current CEO Werner Wenning retires. But laboratory equipment manufacturer Thermo announced that its Chief Operating Officer Marc N. Casper will be promoted to CEO next month. Dekkers will join Bayer's board in January and will transitionally become CEO of Bayer's health care unit, which houses the firm's drug and diabetes products, when Bayer HealthCare CEO Arthur J. Higgins leaves the company in the first half of 2010. Bayer also announced that its chief financial officer, Klaus Kühn, will retire next April